Zhixuan Li
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2
-
- Immune Cell Function and Interaction 3
- Immune cells in cancer 3
-
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Cells and Metastasis 2
- Otorhinolaryngology top 10%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 2
- Co-authors
- Lei ChenTong WuBo ZhengRui WuYanjing ZhuHongyang WangShuai YangGuijuan Luo
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zhixuan Li
19 papers receiving 723 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 303
- Immunology 189
- Oncology 198
- Otorhinolaryngology 31
- Hepatology 45
Countries citing papers authored by Zhixuan Li
This map shows the geographic impact of Zhixuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixuan Li more than expected).
Fields of papers citing papers by Zhixuan Li
This network shows the impact of papers produced by Zhixuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixuan Li. The network helps show where Zhixuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhixuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 44 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 34 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 48 | |
| 11 | 2021 | 22 | |
| 12 | 2021 | 93 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 27 | |
| 16 | 2020 | 81 | |
| 17 | 2019 | 202 | |
| 18 | 2019 | 83 | |
| 19 | 2016 | 18 | |
| 20 | 2013 | 2 |
About Zhixuan Li
Zhixuan Li is a scholar working on Structural Biology, Cancer Research and Immunology, having authored 21 papers that have together received 729 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Immune cells in cancer (3 papers), Cancer Genomics and Diagnostics (3 papers), MicroRNA in disease regulation (2 papers), Cancer Cells and Metastasis (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (303 citations), Immunology (189 citations) and Oncology (198 citations). Zhixuan Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Lei Chen, Tong Wu, Bo Zheng, Rui Wu, Yanjing Zhu, Hongyang Wang, Shuai Yang, Guijuan Luo, Yang Ge and Siyun Shen. Their work appears in journals such as Cancer, Food Chemistry and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.